Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.760
-0.050 (-2.76%)
At close: Dec 18, 2025, 4:00 PM EST
1.700
-0.060 (-3.41%)
After-hours: Dec 18, 2025, 5:15 PM EST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $167.97 million as of December 18, 2025. Its market cap has increased by 14.00% in one year.
Market Cap
167.97M
Enterprise Value
129.22M
1-Year Change
14.00%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $167.97M, an increase of 34.14%. That is a compound annual growth rate of 2.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 167.97M | 1.44% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |